Survival in Unresectable Hepatocellular Carcinoma Treated With a New Immune Checkpoint and Anti-angiogenic Drug Combination

Gastroenterology. 2024 Feb;166(2):350. doi: 10.1053/j.gastro.2023.09.003. Epub 2023 Sep 6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Humans
  • Liver Neoplasms* / drug therapy

Substances

  • Angiogenesis Inhibitors